Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13846 | 745 | 25.2 | 35% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2084 | 4777 | O 6 ALKYLGUANINE DNA ALKYLTRANSFERASE//ALKYLTRANSFERASE//O 6 BENZYLGUANINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SARCNU | Author keyword | 9 | 83% | 1% | 5 |
2 | TAUROMUSTINE | Author keyword | 8 | 70% | 1% | 7 |
3 | S 2250 KAWAGISHI | Address | 8 | 100% | 1% | 5 |
4 | ANTITUMOR DRUG SCREEN | Author keyword | 6 | 100% | 1% | 4 |
5 | L LYSINE DERIVATIVES | Author keyword | 4 | 75% | 0% | 3 |
6 | L ORNITHINE DERIVATIVES | Author keyword | 3 | 100% | 0% | 3 |
7 | NITROSOUREA | Author keyword | 3 | 16% | 2% | 16 |
8 | FOTEMUSTINE | Author keyword | 3 | 15% | 2% | 17 |
9 | NITROXYL FREE RADICAL | Author keyword | 2 | 67% | 0% | 2 |
10 | NITROSOUREAS | Author keyword | 1 | 17% | 1% | 8 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SARCNU | 9 | 83% | 1% | 5 | Search SARCNU | Search SARCNU |
2 | TAUROMUSTINE | 8 | 70% | 1% | 7 | Search TAUROMUSTINE | Search TAUROMUSTINE |
3 | ANTITUMOR DRUG SCREEN | 6 | 100% | 1% | 4 | Search ANTITUMOR+DRUG+SCREEN | Search ANTITUMOR+DRUG+SCREEN |
4 | L LYSINE DERIVATIVES | 4 | 75% | 0% | 3 | Search L+LYSINE+DERIVATIVES | Search L+LYSINE+DERIVATIVES |
5 | L ORNITHINE DERIVATIVES | 3 | 100% | 0% | 3 | Search L+ORNITHINE+DERIVATIVES | Search L+ORNITHINE+DERIVATIVES |
6 | NITROSOUREA | 3 | 16% | 2% | 16 | Search NITROSOUREA | Search NITROSOUREA |
7 | FOTEMUSTINE | 3 | 15% | 2% | 17 | Search FOTEMUSTINE | Search FOTEMUSTINE |
8 | NITROXYL FREE RADICAL | 2 | 67% | 0% | 2 | Search NITROXYL+FREE+RADICAL | Search NITROXYL+FREE+RADICAL |
9 | NITROSOUREAS | 1 | 17% | 1% | 8 | Search NITROSOUREAS | Search NITROSOUREAS |
10 | CHLOROETHYLNITROSOCARBAMOYL AMINO ACIDS | 1 | 100% | 0% | 2 | Search CHLOROETHYLNITROSOCARBAMOYL+AMINO+ACIDS | Search CHLOROETHYLNITROSOCARBAMOYL+AMINO+ACIDS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TCNU | 13 | 71% | 1% | 10 |
2 | SPIN LABELED NITROSOUREAS | 12 | 86% | 1% | 6 |
3 | 2 CHLOROETHYL 3 SARCOSINAMIDE 1 NITROSOUREA | 11 | 78% | 1% | 7 |
4 | SARCOSINAMIDE | 9 | 83% | 1% | 5 |
5 | NITROSOUREAS | 9 | 23% | 5% | 34 |
6 | SK MG 1 | 6 | 100% | 1% | 4 |
7 | CHLOROETHYLNITROSOUREA RESISTANCE | 4 | 67% | 1% | 4 |
8 | N NITROSOUREAS | 4 | 50% | 1% | 6 |
9 | PREDICTIVE DESIGN | 4 | 50% | 1% | 6 |
10 | AMINO ACID AMIDES | 4 | 29% | 2% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
A critical appraisal of the evolution of N-nitrosoureas as anticancer drugs | 1997 | 110 | 426 | 49% |
RELATIONSHIP OF STRUCTURE TO ANTICANCER ACTIVITY AND TOXICITY OF THE NITROSOUREAS IN ANIMAL SYSTEMS | 1986 | 54 | 41 | 80% |
NITROSOUREAS FROM CHEMIST TO PHYSICIAN - CLASSIFICATION AND RECENT APPROACHES TO DRUG DESIGN | 1990 | 20 | 73 | 68% |
METABOLISM OF THE CHLOROETHYLNITROSOUREAS | 1991 | 31 | 28 | 54% |
Focus on Fotemustine | 2006 | 23 | 55 | 27% |
SarCNU (2-chloroethyl-3-sarcosinamide-1-nitrosourea): A novel analogue of chloroethylnitrosourea that is transported by the catecholamine uptake(2) carrier, which mediates increased cytotoxicity | 1996 | 6 | 10 | 70% |
THERAPEUTIC INDEX - A VITAL COMPONENT IN SELECTION OF ANTICANCER AGENTS FOR CLINICAL-TRIAL | 1989 | 38 | 31 | 26% |
In vitro chemotherapy of steroid receptor positive human meningioma low-passage primary cultures with nitrosourea-methionine-steroid conjugates | 1996 | 2 | 14 | 57% |
BIOTRANSFORMATION OF ALKYLNITROSOUREA (A REVIEW) | 1989 | 2 | 60 | 52% |
CHLOROETHYLNITROSOUREA CANCER CHEMOTHERAPEUTIC-AGENTS | 1982 | 41 | 21 | 62% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | S 2250 KAWAGISHI | 8 | 100% | 0.7% | 5 |
2 | PHYSIOL PATHOPHYSIOL PHARMACOL | 1 | 21% | 0.4% | 3 |
3 | BPMERU | 1 | 50% | 0.1% | 1 |
4 | BREEDING AGR | 1 | 50% | 0.1% | 1 |
5 | UNITE ONCOTHER IE PL | 1 | 50% | 0.1% | 1 |
6 | HEMATOL UNIT BONE MARROW TRANSPLANTAT | 0 | 25% | 0.1% | 1 |
7 | HEMATOL ONCOL STEM CELL TRANSPLANTAT UNIT | 0 | 11% | 0.3% | 2 |
8 | CANC TREATMENTNIH | 0 | 17% | 0.1% | 1 |
9 | EARLY CLIN STUDIES GRP | 0 | 14% | 0.1% | 1 |
10 | MED VINCENT T LOMBARDI CANC | 0 | 14% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000126737 | UNITE BIOTECHNOL BIOINGN//RECHUNITE BIOTECHNOL BIOINGN//COLCHICINE BINDING SITE LIGANDS |
2 | 0.0000117513 | QUIM FIS EQI//ANAL VALEUR BIOL ALIMENTS//QUIM FIS EQ 1 |
3 | 0.0000091508 | N N N TRIETHYLENEPHOSPHORAMIDE//THIOTEPA MERCAPTURATE//TEPA |
4 | 0.0000086764 | O 6 ALKYLGUANINE DNA ALKYLTRANSFERASE//O 6 BENZYLGUANINE//ALKYLTRANSFERASE |
5 | 0.0000085321 | PHOSPHOLIPIDS COMPOSITION//LIVER INDEX//AGING ASSOCIATED DISEASES |
6 | 0.0000076463 | INTRACAROTID CHEMOTHERAPY//RMP 7//INTRACAROTID INFUSION |
7 | 0.0000058304 | LEHRSTUHL PHARMAZEUT CHEM 2//GRP RECH ONCOL ENDOCRINOL MOL//PORPHYRIN PLATINUM CONJUGATES |
8 | 0.0000058183 | PEPTICHEMIO//ALKYLATING PEPTIDES//HUMAN MYELOMA CELLS |
9 | 0.0000053933 | MTIC//DIPARTIMENTO FARMACOCHIM TOSSICOL BIOL//VLAK PROTOCOL |
10 | 0.0000052498 | VNP40101M//CLORETAZINE//NEW ANTICANCER AGENT |